The Samuel Waxman Cancer Research Foundation announced that it awarded $1.4 million in new grants to scientists conducting groundbreaking research

The Samuel Waxman Cancer Research Foundation Invests
More Than $2 Million In Cancer Research Funding 
Seven Investigators Awarded a New Round of 2019-2021 Grants and

Joined a Record Number of Funded Scientists

The Samuel Waxman Cancer Research Foundation (SWCRF) announced that it awarded $1.4 million in new grants to scientists conducting groundbreaking research. The grants will fund research in aging and cancer, differentiation therapy, abnormal gene expression, and epigenetic therapies.

These grants are part of more than $2 million in donor-supported funding that the SWCRF has allocated this year for cancer research. In addition, the SWCRF now funds a record 50 physician-scientists as part of the Foundation’s Institute Without Walls, which breaks down institutional and clinical expertise silos by promoting collaboration.

“The SWCRF is making a substantial investment in funding cutting-edge research ideas that show remarkable promise for uncovering abnormal gene expression in cancer and developing less-toxic therapies. We welcome these scientists to the SWCRF Institute Without Walls, which will expand our network of scientists committed to cross-disciplinary and cross-institutional collaboration as a mechanism to hasten discoveries,” said Samuel Waxman, MD, founder and CEO of the SWCRF.

Earlier this year, the SWCRF issued an RFA to cancer research institutions around the world. Proposals underwent a rigorous review process conducted by the Scientific Advisory Board of the SWCRF. Grant recipients are expected to declare collaboration with at least one other SWCRF-funded investigator to join publications, grant application and other mechanisms that support the mission of the Foundation. These investigators present a progress report of their research findings through participation at the annual SWCRF symposium for peer review.

“This level of funding would not be possible without the generous support from dedicated donors of the SWCRF and we are extraordinarily grateful,” said William T. Sullivan, executive director at the SWCRF. “We anticipate even more breakthroughs by directing an increased level of support to these outstanding scientists who have a track record of novel approaches to cancer cures.”

The 2019-2021 individual research grant recipients are:

cid:image003.png@01D55F27.180A5030Tyler J. Curiel, MD, MPH
The University of Texas Health Science Center at San Antonio

Research focus: Age effects of T cell stem cells, cancer stem cells and immune checkpoints on cancer immunotherapy

cid:image004.png@01D55F27.180A5030Ronald M. Evans, PhD
The Salk Institute for Biological Studies

Research focus: FXR as a novel therapeutic target in Colitis-induced Colorectal Cancer

cid:image005.png@01D55F27.180A5030Maria E. Figueroa, MD
University of Miami

Research focus: The role of age-related reprogramming of KLF6 in HSC dysfunction and myeloid malignancies

cid:image006.png@01D55F27.180A5030Jan Karlseder, PhD
The Salk Institute for Biological Studies

Research focus: The regulation of proliferative boundaries by autophagy

cid:image007.png@01D55F27.180A5030Ross Levine, MD
Memorial Sloan Kettering Cancer Center

Research focus: Determining the role of somatic clonal evolution in aging, hematopoiesis, and predisposition to malignancies

cid:image008.png@01D55F27.180A5030Joel Neilson, PhD
Baylor College of Medicine One Baylor Plaza

Research focus: In vivo disruption of a novel translation pre-initiation complex as a putative therapeutic vulnerability for breast cancer differentiation therapy

cid:image009.png@01D55F27.180A5030Emmanuelle Passegue, PhD
Columbia University

Research focus: Autophagy and Hematopoietic stem cell function in aging and leukemia

About the Samuel Waxman Cancer Research Foundation (SWCRF):
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe.

For more information on SWCRF, visit:
For more information on The Hamptons Happening, ticket packages and sponsorships, visit or call 212-867-4502.

Facebook:           WaxmanCancer
Instagram:          @waxmancancer
Twitter: @waxmancance copy

No hay comentarios: